Clinical Trial Update: Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared [Phase 3]

View source ↗

Summary

A Phase 3 long-term follow-up study comparing two dosing schedules of the combined hepatitis A and B vaccine; results completed with posted results in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B

Drugs mentioned

• Combined hepatitis A and B vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Hepatitis A | Phase 3 | Status: COMPLETED | Results posted: 2009-06-04